Thursday, December 12, 2019
News on Pathogens and Preparedness
Global Biodefense
No Result
View All Result
  • Featured
  • Pathogens

    Tracing the Ancestral Genome of The Plague

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    Bacillus anthracis concept drawing

    Decontamination of Bacillus Spores from Drinking Water Infrastructure

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    red agar plate with cultured bacteria

    Study Shows Virulence of B. pseudomallei Strain in Aerosol Model

    Turns Out, Bat Influenza Can Give You the Flu

    Turns Out, Bat Influenza Can Give You the Flu

    Crimean-Congo Hemorrhagic Fever

    Crimean Congo Countermeasures: Researchers Investigate CCHFV-RDRp

    Yersinia pestis

    Researchers Optimize Novel Hexaplex PCR Assay for Simultaneous Detection of Anthrax and Plague Pathogens

  • Directory
  • Job Board
  • Funding
    • Contracts + Grants
    • Funding Awards
    • Requests for Information
    • Industry News
  • Events
    • All Events
    • Conferences + Meetings
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Headlines
  • Subscribe
  • Featured
  • Pathogens

    Tracing the Ancestral Genome of The Plague

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    Bacillus anthracis concept drawing

    Decontamination of Bacillus Spores from Drinking Water Infrastructure

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    red agar plate with cultured bacteria

    Study Shows Virulence of B. pseudomallei Strain in Aerosol Model

    Turns Out, Bat Influenza Can Give You the Flu

    Turns Out, Bat Influenza Can Give You the Flu

    Crimean-Congo Hemorrhagic Fever

    Crimean Congo Countermeasures: Researchers Investigate CCHFV-RDRp

    Yersinia pestis

    Researchers Optimize Novel Hexaplex PCR Assay for Simultaneous Detection of Anthrax and Plague Pathogens

  • Directory
  • Job Board
  • Funding
    • Contracts + Grants
    • Funding Awards
    • Requests for Information
    • Industry News
  • Events
    • All Events
    • Conferences + Meetings
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Headlines
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

CDC Approves Partial Resumption of USAMRIID Select Agent Research

by Global Biodefense
23 Nov 2019
CDC Approves Partial Resumption of USAMRIID Select Agent Research

The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) will resume limited research, following a successful recent inspection by the Centers for Disease Control (CDC) and Prevention.

The announcement was made in on Nov. 22 in official statement by Caree Vander Linden, spokesperson for USAMRIID.

In July 2019, the CDC suspended USAMRIID’s registration to work with Biological Select Agents and Toxins, citing issues with its biosafety program.

In the past four months, USAMRIID has engaged in ongoing discussions with the CDC while taking a comprehensive approach to improving infrastructure, training, compliance, and biosafety standards. In early November, the CDC’s Division of Select Agents and Toxins (DSAT) conducted a site inspection of USAMRIID to assess its progress.

The CDC provided additional conditions for research to gradually resume, which include allowing a limited number of studies to be performed. Work on these studies will be conducted in specified laboratories only, by select personnel who have undergone extensive training. These limited activities will afford USAMRIID and DSAT the opportunity to evaluate the newly implemented processes and procedures.

The CDC will continue to conduct on-site evaluations to observe laboratory personnel. Real-time observations will be conducted at all supervisory levels in order to ensure that practices are in compliance with the revised biosafety plan and that any deviation is corrected on the spot.

The overall effort to restore USAMRIID to full operational capability utilizes a “crawl, walk, run” approach to getting back into containment laboratory operations, according to Colonel E. Darrin Cox, the Institute’s commander. “Our concept is to start with a small group of people, secure approval for a limited number of studies, and then gradually expand to include more research projects across additional laboratory suites,” Cox said. “Resuming operations in this
stepwise fashion also allows for continuous communication with the CDC and our Army leadership.”

Leaders from the U.S. Army Futures Command and the U.S. Army Medical Research and Development Command, USAMRIID’s higher headquarters, have been engaged in the effort to bring USAMRIID back online, according to Brigadier General Michael J. Talley, Commanding General, USAMRDC and Fort Detrick. “We are committed, first and foremost, to the safety of our workforce and the surrounding community,” said Talley. “We are also committed to restoring USAMRIID to full mission capability so we can continue doing the critical research that protects our Warfighters and citizens, in this country and around the world.”

RELATED READING

  • DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight
  • How Does USAMRIID Shut Down Impact Nation’s Bioterrorism Laboratory Response Network?
  • Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994
  • Lawmakers Seek Answers on USAMRIID Shutdown, BioDetection 21 Capabilities
Tags: BiosafetyBSL-4Editor PickSelect AgentsUSAMRIID
Previous Post

Arctic Ice Melt Lets Deadly PDV Disease Spread from Atlantic

Next Post

Inflammatix Wins BARDA Backing for Diagnostic to Rapidly Distinguish Bacterial from Viral Infections

Related Posts

Arctic Ice Melt Lets Deadly PDV Disease Spread from Atlantic
Biosecurity

Arctic Ice Melt Lets Deadly PDV Disease Spread from Atlantic

23 Nov 2019
Salad Bars and Water Systems are Easy Targets for Bioterrorists – and America’s Monitoring System is Woefully Inadequate
Biosecurity

Salad Bars and Water Systems are Easy Targets for Bioterrorists – and America’s Monitoring System is Woefully Inadequate

17 Nov 2019
African Swine Fever: An Unexpected Threat to the Global Supply of Heparin
Biosecurity

African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

7 Oct 2019
Biosafety Levels in Laboratories – What is the Difference?
Biosecurity

Biosafety Levels in Laboratories – What is the Difference?

22 Sep 2019
Russian Biosafety Level 4 Laboratory Buildings
Biosecurity

Explosion Confirmed at Russian Lab Storing Smallpox, Ebola

21 Sep 2019
DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight
Biosecurity

DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight

9 Sep 2019
Load More
Next Post
Klebsiella pneumoniae

Inflammatix Wins BARDA Backing for Diagnostic to Rapidly Distinguish Bacterial from Viral Infections

Headlines

  • Artificial Intelligence and Big Data Analytics for Biodefence: Implications for Threat Assessment And Biosurveillance
  • African Swine Fever Kills More Than 20 Wild Boar in Poland
  • Samoa Measles Outbreak: Death Toll Rises To 53, Mostly Children
  • OPCW Defends Syria Attack Conclusions After Document Leaks
  • Osama bin Laden’s “Anthrax Scientist” Freed by Malaysia

Recommended

  • Highly Sensitive Epigenomic Technology Combats Disease
  • Interview: Ambassador Bonnie Jenkins on 8 years of Combating WMD Terrorism
  • There’s No Such Thing as Just-in-Time Healthcare and Public Health Preparedness
  • Threat Detection in Your Pocket
  • Inflammatix Wins BARDA Backing for Diagnostic to Rapidly Distinguish Bacterial from Viral Infections

Featured Partner

  • About
  • Contact
  • Privacy
  • Subscribe

© 2019 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • Pathogens
  • Directory
  • Job Board
  • Funding
    • Contracts + Grants
    • Funding Awards
    • Requests for Information
    • Industry News
  • Events
    • All Events
    • Conferences + Meetings
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Headlines
  • Subscribe

© 2019 Stemar Media Group LLC